Cargando…

The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory

In a previous study the simple, naturally derived coumarin scopoletin (SCT) was identified as an inhibitor of acetylcholinesterase (AChE), using a pharmacophore-based virtual screening approach. In this study the potential of SCT as procholinergic and cognition-enhancing therapeutic was investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Hornick, A., Lieb, A., Vo, N.P., Rollinger, J.M., Stuppner, H., Prast, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212650/
https://www.ncbi.nlm.nih.gov/pubmed/21945033
http://dx.doi.org/10.1016/j.neuroscience.2011.09.006
_version_ 1782216000848003072
author Hornick, A.
Lieb, A.
Vo, N.P.
Rollinger, J.M.
Stuppner, H.
Prast, H.
author_facet Hornick, A.
Lieb, A.
Vo, N.P.
Rollinger, J.M.
Stuppner, H.
Prast, H.
author_sort Hornick, A.
collection PubMed
description In a previous study the simple, naturally derived coumarin scopoletin (SCT) was identified as an inhibitor of acetylcholinesterase (AChE), using a pharmacophore-based virtual screening approach. In this study the potential of SCT as procholinergic and cognition-enhancing therapeutic was investigated in a more detailed way, using different experimental approaches like measuring newly synthesized acetylcholine (ACh) in synaptosomes, long-term potentiation (LTP) experiments in hippocampal slices, and behavior studies. SCT enhanced the K(+)-stimulated release of ACh from rat frontal cortex synaptosomes, showing a bell-shaped dose effect curve (E(max): 4 μM). This effect was blocked by the nicotinic ACh receptor (nAChR) antagonists mecamylamine (MEC) and dihydro-β-erythroidine (DHE). The nAChR agonist (and AChE inhibitor) galantamine induced a similar increase in ACh release (E(max): 1 μM). SCT potentiated LTP in hippocampal slices of rat brain. The high-frequency stimulation (HFS)-induced, N-methyl-D-aspartate (NMDA) receptor dependent LTP of field excitatory postsynaptic potentials at CA3-CA1 synapses was greatly enhanced by pre-HFS application of SCT (4 μM for 4 min). This effect was mimicked by nicotine (2 μM) and abolished by MEC, suggesting an effect on nAChRs. SCT did not restore the total inhibition of LTP by NMDA receptor antagonist d, l-2-amino-5-phosphonopentanoic acid (AP-5). SCT (2 μg, i.c.v.) increased T-maze alternation and ameliorated novel object recognition of mice with scopolamine-induced cholinergic deficit. It also reduced age-associated deficits in object memory of 15–18-month-old mice (2 mg/kg sc). Our findings suggest that SCT possesses memory-improving properties, which are based on its direct nAChR agonistic activity. Therefore, SCT might be able to rescue impaired cholinergic functions by enhancing nAChR-mediated release of neurotransmitters and promoting neural plasticity in hippocampus.
format Online
Article
Text
id pubmed-3212650
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Elsevier Science
record_format MEDLINE/PubMed
spelling pubmed-32126502011-12-28 The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory Hornick, A. Lieb, A. Vo, N.P. Rollinger, J.M. Stuppner, H. Prast, H. Neuroscience Cognitive, Behavioral, and Systems Neuroscience In a previous study the simple, naturally derived coumarin scopoletin (SCT) was identified as an inhibitor of acetylcholinesterase (AChE), using a pharmacophore-based virtual screening approach. In this study the potential of SCT as procholinergic and cognition-enhancing therapeutic was investigated in a more detailed way, using different experimental approaches like measuring newly synthesized acetylcholine (ACh) in synaptosomes, long-term potentiation (LTP) experiments in hippocampal slices, and behavior studies. SCT enhanced the K(+)-stimulated release of ACh from rat frontal cortex synaptosomes, showing a bell-shaped dose effect curve (E(max): 4 μM). This effect was blocked by the nicotinic ACh receptor (nAChR) antagonists mecamylamine (MEC) and dihydro-β-erythroidine (DHE). The nAChR agonist (and AChE inhibitor) galantamine induced a similar increase in ACh release (E(max): 1 μM). SCT potentiated LTP in hippocampal slices of rat brain. The high-frequency stimulation (HFS)-induced, N-methyl-D-aspartate (NMDA) receptor dependent LTP of field excitatory postsynaptic potentials at CA3-CA1 synapses was greatly enhanced by pre-HFS application of SCT (4 μM for 4 min). This effect was mimicked by nicotine (2 μM) and abolished by MEC, suggesting an effect on nAChRs. SCT did not restore the total inhibition of LTP by NMDA receptor antagonist d, l-2-amino-5-phosphonopentanoic acid (AP-5). SCT (2 μg, i.c.v.) increased T-maze alternation and ameliorated novel object recognition of mice with scopolamine-induced cholinergic deficit. It also reduced age-associated deficits in object memory of 15–18-month-old mice (2 mg/kg sc). Our findings suggest that SCT possesses memory-improving properties, which are based on its direct nAChR agonistic activity. Therefore, SCT might be able to rescue impaired cholinergic functions by enhancing nAChR-mediated release of neurotransmitters and promoting neural plasticity in hippocampus. Elsevier Science 2011-12-01 /pmc/articles/PMC3212650/ /pubmed/21945033 http://dx.doi.org/10.1016/j.neuroscience.2011.09.006 Text en © 2011 Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/3.0/ Open Access under CC BY-NC-ND 3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) license
spellingShingle Cognitive, Behavioral, and Systems Neuroscience
Hornick, A.
Lieb, A.
Vo, N.P.
Rollinger, J.M.
Stuppner, H.
Prast, H.
The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
title The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
title_full The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
title_fullStr The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
title_full_unstemmed The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
title_short The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
title_sort coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic- and age-impaired memory
topic Cognitive, Behavioral, and Systems Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3212650/
https://www.ncbi.nlm.nih.gov/pubmed/21945033
http://dx.doi.org/10.1016/j.neuroscience.2011.09.006
work_keys_str_mv AT hornicka thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT lieba thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT vonp thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT rollingerjm thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT stuppnerh thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT prasth thecoumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT hornicka coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT lieba coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT vonp coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT rollingerjm coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT stuppnerh coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory
AT prasth coumarinscopoletinpotentiatesacetylcholinereleasefromsynaptosomesamplifieshippocampallongtermpotentiationandamelioratesanticholinergicandageimpairedmemory